Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
safest obesity drug in trial
Recs
Pick up post dilution, ride it to a month before the PDUFA
Recs
It is kind of sad that this stock is one of my best performers. The George Costanza method of investing truly works...
Recs
There are a lot of fat people out there who 'need a little help from their drugs.'
Recs
this dog is traded at its simple cash reserves, means their technologies are worth nothing, or yes maybe totaly undervalued! technicals very bad, biotech with huge cashburnrate and fda rejection!
Recs
Good news is that their competition is also having problems with FDA.
Recs
Arna's manipulation is well known,and also its efficacy.Arena is manipulated with out any doubt by diet food companies and {DOCTORS}who practice weight loss surgery,large pharmaceutical companies who donate large sums to elected politicians.If any person with healthy mind thinks about it any drug company before presenting any drug to FDA they go through many phases with FDA's approval on each and every phase.What went wrong only insiders and FDA panel can tell us the truth.
Recs
Bravo Pick.
Recs
obesity play, lottery ticket.
Recs
Yes, I know: their weight loss drug has gone down the drain. But, consider: if they are even a little successful going forward, can you imagine how much money they will make? Do you truly understand how fat and overweight Americans are?
ATTENTION: put down that can of beer and bag of pork rinds!!
Recs
Something definitely happen today to make this jump 41%. I new to the game but i believe this stock is very undervalued.
Recs
No chance for approval
Recs
They have the safest weight loss drug.
Recs
ARNA has been so badly bashed that one cannot help but expect it to hit back and get the shorts running to cover
Recs
ARNA. Someday in the future Arena Pharma will be $40+ per share
Recs
NOVEMBER 2010
@ or below 1.65 looking for 50%
GOD Bless!
Recs
NICE TRADE HERE. SHOULD GET A GOOD POP TO THE UPSIDE. THE 7'S IS A REAL POSSIBILITY NEAR TERM.
Recs
ARNA has been manipulated,at least that is my true feeling {i am not ARNA SHARE HOLDRE} but it is not fair to kill a USA bio company and causing financial burden to it's share holder,it has promising outcome,{safty,efficacy}wise,if you noticed everything was ok until the day of panel meeting suddenly rat tumor growth was an issue.Arna has come so far with III phases,no human tumor growth so far has been brought by any of panel members,there is something not right FDA is also being bought by some other manipulaters.God may bless America and help the bio companies from uneducated and unfairFDA members.[Will FDA pass this drug for RATS}it is confusing,to me it is.
Recs
The story isn't finished on obesity drug. This is seeing similar history to Dendren (DNDN), and will come back after further trials which remove the doubts on the drug also being the root cause for any tumors that were seen in trials on rats.
Recs
great entry point here, any positive news the shorts will get squeezed and send it to the SKY.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 132 : 1 2 3 4 5 6 7 Next »